Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

South Campus first in SA to introduce new online platform for educators
2016-05-25

Description: South Campus online platform for educators  Tags: South Campus online platform for educators

Dr Whitty Green (DHET), Phillip Dikgomo (NDBE), Ernst Stals (Free State Department of Education), Isaac Mogotsi (Nothern Cape Department of Education), Tsatsi Montso (Free State Department of Education), Prof Daniella Coetzee (Principal: South Campus), Steven Bailey (Academic Partnerships), and Prof Judy Zimny (Academic Partnerships)
Photo: Eugene Seegers

The South Campus of the University of the Free State (UFS) has become the first in South Africa to introduce a completely online platform for educators to obtain the Advanced Certificate in Teaching (ACT) in either Foundation, Intermediate, or Senior Phase.

Beginning with the first start date of 4 July 2016, this platform will be offered in nine or ten 8-week sessions. It will provide educators the opportunity to complete these certificates in 18-20 months compared to the 24 months usually required by part-time university students.  Academic and technological support will also be provided.

Unique platform

Prof Daniella Coetzee, Principal of South Campus, said that she is thrilled, “as this opportunity for educators to earn a qualification 100% online - is a first for both the UFS and South Africa.”  This opportunity represents tremendous strides in providing options for South African educators.

According to Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS, human connectivity is a key component of education: “We should never reduce education to a stranger at a distance without any human interaction. That is also why the UFS has been consistent in promoting not only its Academic Project, but the Human Project as well.” He said that it would not be possible to extend second-chance opportunities to students without partnerships with government, non-profit organisations, local and international academic partners, and other external stakeholders.

Specific challenges addressed

In her presentation, Prof Judy Zimny, who is affiliated with Academic Partnerships (a company that has supported more than 40 universities in providing high-quality online programmes for educators) aligned a number of the challenges described by South African leaders in supporting educators with opportunities now available through online education as a result of recent strides in learning technologies.

Various members of the national education sector were also present at the workshop to give their input: Isaac Mogotsi (Northern Cape Department of Education), Phillip Dikgomo (National Department of Basic Education - NDBE), Dr Whitty Green (Department of Higher Education and Training - DHET), Tsatsi Montso (Free State Department of Education), and Ernst Stals (Free State Department of Education).

For educators interested in pursuing an Advanced Teaching Certificate (ACT), the website will soon be populated with all admission and enrolment information for programmes starting on 4 July 2016, 29 August 2016, and 24 October 2016.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept